FDA OKs C. difficile test from First Light Diagnostics

2021-07-21

The FDA has given marketing clearance to First Light Diagnostics for its SensiTox C. difficile Toxin Test and its MultiPath Analyzer that can deliver results within 35 minutes.

Full story:

AdvaMed SmartBrief

Medical devices, health care information systems and diagnostic products

Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart.